Abstract
Urinary human epidermal growth factor levels were assayed in diabetic patients and controls before and after surgery. The preoperative levels in the diabetic patients were decreased and postoperatively, did not show the trough and peak pattern which was seen in the controls.
References
Carpenter G, Cohen S. Epidermal growth factor. Ann Rev Biochem 1979; 48: 193–216.
Hollenberg MD. Epidermal growth factor—Urogastrone, a polypeptide acquiring hormonal status. Vitamins and Hormones 1979; 37: 69–110.
Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962; 237: 1555–1562.
Starkey RH, Cohen S, Orth DN. Epidermal growth factor: Identification of a new hormone in human urine. Nature 1975; 189: 800–802.
Mattila A-L, Pasternack A, Vinikka L, Perheentupa J. Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease. J Clin Endocrinol 1986; 62: 1180–1183.
Abe Y, Miyake M, Sagawa T, Kimura S. Urine human epidermal growth factor (hEGF) levels following surgery. Jpn J Surg 1988; 18: 641–646.
Dailey GE, Kraus JW, Orth DN. Homologous radioimmunoassay for human epidermal growth factor (Urogastrone). J Clin Endocrinol Metabol 1978; 46: 929–936.
Abe Y, Sagawa T, Sakai K, Kimura S. Enzyme-linked immunosorbent assay (ELISA) for human epidermal growth factor (hEGF). Clin Chim Acta 1987; 168: 87–95.
Mathiesen ER, Nexo E, Hommel E, Parving H-H. Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy. Diabetic Med 1989; 6: 121–126.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abe, Y., Miyake, M., Horiuchi, A. et al. Decreased urinary epidermal growth factor levels in diabetic patients. The Japanese Journal of Surgery 21, 485–486 (1991). https://doi.org/10.1007/BF02470982
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470982